IKT
Inhibikase Therapeutics Inc
2.20$
-4.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
Inhibikase Therapeutics Inc (IKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -0.1 | 0.7 | -0.3 | -1.1 | -14 | -17 | -18 | -19 | -28 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | |
| 0.3 | 0.3 | 0.6 | 1.4 | 0.6 | 1.5 | 0.5 | 0.5 | 8.1 | 15 | |
| 0.3 | 0.3 | 1.4 | 2.2 | 2.2 | 2.3 | – | – | – | – | |
| 0.2 | 0.0 | 1.5 | 1.6 | -0.5 | -1.8 | 0.2 | 0.2 | 0.2 | 0.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | |
| 0.1 | 0.1 | 0.1 | – | – | – | -16 | 12 | -37 | 2.1 | |
| – | – | – | – | – | 0.1 | – | – | – | – | |
| – | – | – | – | – | -0.1 | – | – | – | – | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.3 | 0.0 | -0.2 | 0.0 | – | – | |
| 0.0 | 0.1 | -0.4 | 0.0 | 15 | 41 | -0.2 | 8.4 | 103 | 108 | |
| -0.1 | 0.0 | 0.4 | -0.4 | 14 | 27 | -34 | 2.0 | 47 | 83 | |
| 0.0 | -0.1 | 0.7 | -0.3 | -1.1 | -14 | -18 | -18 | -19 | -28 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.